Dihydrolipoamide dehydrogenase
Dihydrolipoamide dehydrogenase[edit | edit source]
Structure of dihydrolipoamide dehydrogenase
Dihydrolipoamide dehydrogenase (DLD) is an essential enzyme involved in the metabolism of carbohydrates and fatty acids. It plays a crucial role in the process of energy production within cells. DLD is a member of the pyridine nucleotide-disulfide oxidoreductase family and is found in various organisms, including humans.
Structure[edit | edit source]
DLD is a homodimeric enzyme, meaning it consists of two identical subunits. Each subunit contains three distinct domains: the N-terminal domain, the central domain, and the C-terminal domain. The N-terminal domain contains the active site, where the catalytic reaction takes place. The central domain acts as a linker between the N-terminal and C-terminal domains, while the C-terminal domain is responsible for the dimerization of the enzyme.
Function[edit | edit source]
DLD plays a critical role in the process of cellular respiration. It is a key component of the pyruvate dehydrogenase complex (PDC), which is responsible for converting pyruvate, a product of glycolysis, into acetyl-CoA. Acetyl-CoA is further utilized in the citric acid cycle to generate ATP, the main energy currency of the cell.
DLD acts as a catalyst in the transfer of electrons from dihydrolipoamide, a coenzyme, to NAD+, a coenzyme. This transfer of electrons is essential for the regeneration of the active form of lipoamide, which is required for the continuous functioning of the PDC. DLD also plays a role in the metabolism of other alpha-keto acids, such as alpha-ketoglutarate and branched-chain alpha-keto acids.
Clinical Significance[edit | edit source]
Mutations in the gene encoding DLD can lead to a rare genetic disorder known as dihydrolipoamide dehydrogenase deficiency. This condition is characterized by a deficiency in DLD activity, resulting in impaired energy production and the accumulation of toxic metabolites. Symptoms of this disorder can vary widely and may include developmental delay, neurological abnormalities, muscle weakness, and lactic acidosis.
References[edit | edit source]
See Also[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
